The LeonaBio rebrand comes from the name Leona, which means lioness and reflects the company’s “commitment to leadership, resilience, and innovation,” CEO Mark Litton, Ph.D., said. More: Athira Pharma roars into the new year with rebrand to LeonaBio Source: fierce
read moreOrca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the commercialization of a blood cancer cell therapy. More: Orca rides 0M funding wave toward cancer cell therapy launch Source: fierce
read moreAdd Johnson & Johnson to the list of biopharma giants that have struck most-favored-nation (MFN) drug pricing deals with the Trump administration. The company also announced plans to build new manufacturing facilities in Pennsylvania and North Carolina. More: J&J strikes
read moreEarly launch numbers of Brinsupri are so strong that Insmed couldn’t wait for the J.P. Morgan Healthcare Conference to share them. The first-in-class inflammatory drug shattered Wall Street estimates in its first full quarter on the market, fueling fresh confidence
read moreThe next phase of Novartis’ $23 billion U.S. investment drive will center on a 35,000-square-foot radioligand therapy (RLT) facility in Winter Park, Florida. Joining established plants in Novartis’ American RLT network in Indiana, New Jersey and California, the new facility
read more© 1994 - 2026 B.M. Pharmaceuticals